Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SFXN4 pseudogene 1 (SFXN4P1) is a pseudogene, meaning it is a DNA sequence similar to the functional sideroflexin 4 gene (SFXN4) but does not produce a functional protein product. Pseudogenes typically arise from duplication or retrotransposition events and may no longer be actively transcribed or translated. As such, SFXN4P1 does not encode a protein and is not considered a therapeutic target, receptor, enzyme, transporter, or biologically active molecule. It should not be confused with the functional SFXN4 gene, which plays a role in mitochondrial complex I assembly and has been implicated in certain diseases[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sideroflexin 4 pseudogene 1 (SFXN4P1).